Skip to main content

In Patients with Only One or Two Oocytes, Is IVF-ET or ICSI Better?

  • Chapter
Frontiers in Gynecological Endocrinology

Abstract

One of the aims of assisted reproduction technologies (ART) is the recruitment of multiple follicles ensuring the recovery of good-quality oocytes upon controlled ovarian hyperstimulation (COH). In recent years, the number of patients in whom few oocytes are obtained in response to COH is increasing. This phenomenon mainly is probably related to the postponement of childbearing to the fourth decade of life. In this group of patients, multifollicular response to COH remains a challenge, but the optimisation of laboratory strategies may help to maximise their chances of pregnancy. Ovarian response to COH varies widely among patients and is strictly dependent on the size of the ovarian pool of resting follicles, the so-called ovarian reserve [1]. In women with a reduced ovarian reserve, a poor ovarian response results in a low number of retrieved oocytes despite the high dose of gonadotropins administered. Hence, although tests for predicting ovarian reserve are available [2], the parameter that best categorises a woman as a ‘poor responder’ remains the ovarian response itself. The incidence of poor ovarian response (POR) is estimated between 9 and 24 % [3–5]. This value increases with age [3, 5] reaching about 50 % in women over 40 years [6]. Women who respond poorly to COH have pregnancy rates that vary from 7.6 to 17.5 %, while in normal responders, they vary from 25.9 to 36.7 %. Female age plays a distinct role in predicting poor response to COH; in fact, older poor responders have lower pregnancy rates (ranging between 1.5 and 12.7 %) compared with younger poor responders (ranging between 13.0 and 35 %) [2]. A second predicting factor of pregnancy outcome in poor responders is the degree of poor response. A lower number of retrieved oocytes results in fewer embryos to transfer and a lower chance of pregnancy, in addition to the expected negative effect of poor ovarian function on oocyte quality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 64.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lashen H, Ledger W, Lopez-Bernal A, Barlow D (1999) Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14:964–969

    Article  CAS  PubMed  Google Scholar 

  2. Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL (2012) The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update 18:1–11

    Article  CAS  PubMed  Google Scholar 

  3. Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S (1991) Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf 8:33–36

    Article  CAS  PubMed  Google Scholar 

  4. Surrey ES, Schoolcraft WB (2000) Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73:667–676

    Article  CAS  PubMed  Google Scholar 

  5. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9:61–76

    Article  CAS  PubMed  Google Scholar 

  6. Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L (2011) ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26:1616–1624

    Article  CAS  PubMed  Google Scholar 

  7. Oehninger S, Gosden RG (2002) Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod 17:2237–2242

    Article  PubMed  Google Scholar 

  8. Van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N (2005) Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril 83:612–617

    Article  PubMed  Google Scholar 

  9. Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J (1998) Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod 13:2126–2129

    Article  CAS  PubMed  Google Scholar 

  10. Gozlan I, Dor A, Farber B, Meirow D, Feinstein S, Levron J (2007) Comparing intracytoplasmic sperm injection and in vitro fertilization in patients with single oocyte retrieval. Fertil Steril 87:515–518

    Article  PubMed  Google Scholar 

  11. Borini A, Gambardella A, Bonu MA, Dal Prato L, Sciajno R, Bianchi L et al (2009) Comparison of IVF and ICSI when only few oocytes are available for insemination. Reprod Biomed Online 19:270–275

    Article  PubMed  Google Scholar 

  12. Artini PG, Obino MER, Carletti E, Pinelli S, Ruggiero M, Di Emidio G et al (2013) Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging. Gynecol Endocrinol 29:997–1001

    Article  CAS  PubMed  Google Scholar 

  13. Palermo G, Joris H, Devroey P, Van Steirteghem AC (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340:17–18

    Article  CAS  PubMed  Google Scholar 

  14. Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD (1994) Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum Reprod 9:2051–2057

    CAS  PubMed  Google Scholar 

  15. Calderón G, Belil I, Aran B, Veiga A, Gil Y, Boada M et al (1995) Intracytoplasmic sperm injection versus conventional in-vitro fertilization: first results. Hum Reprod 10:2835–2839

    PubMed  Google Scholar 

  16. Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Amin YM (1996) Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen. J Assist Reprod Genet 13:38–42

    Article  CAS  PubMed  Google Scholar 

  17. Khamsi F, Yavas Y, Roberge S, Wong JC, Lacanna IC, Endman M (2001) Intracytoplasmic sperm injection increased fertilization and good-quality embryo formation in patients with non-male factor indications for in vitro fertilization: a prospective randomized study. Fertil Steril 75:342–347

    Article  CAS  PubMed  Google Scholar 

  18. Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A (1999) Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod 14:2474–2479

    Article  CAS  PubMed  Google Scholar 

  19. Kim HH, Bundorf MK, Behr B, McCallum SW (2007) Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril 88:622–628

    Article  PubMed  Google Scholar 

  20. Fang C, Tang J, Huang R, Li LL, Zhang MF, Liang XY (2012) Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained. J Gynecol Obstet Biol Reprod. doi:10.1016/j.jgyn.2012.06.004

    Google Scholar 

  21. Xi Q, Zhu L, Hu J, Wu L, Zhang H (2012) Should few retrieved oocytes be as an indication for intracytoplasmic sperm injection? J Zhejiang Univ Sci B 13:717–722

    Article  PubMed Central  PubMed  Google Scholar 

  22. Ikawa M, Inoue N, Benham AM, Okabe M (2010) Fertilization: a sperm’s journey to and interaction with the oocyte. J Clin Invest 120:984–994

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Liu F, Qiu Y, Zou Y, Deng Z-H, Yang H, Liu DY (2011) Use of zona pellucida-bound sperm for intracytoplasmic sperm injection produces higher embryo quality and implantation than conventional intracytoplasmic sperm injection. Fertil Steril 95:815–818

    Article  PubMed  Google Scholar 

  24. Kunathikom S, Makemaharn O, Suksompong S, Laokirkkiat P (2001) Chromosomal analysis of “failed-fertilized” human oocytes resulting from in-vitro fertilization and intracytoplasmic sperm injection. J Med Assoc Thai 84:532–538

    CAS  PubMed  Google Scholar 

  25. Miller JE, Smith TT (2001) The effect of intracytoplasmic sperm injection and semen parameters on blastocyst development in vitro. Hum Reprod 16:918–924

    Article  CAS  PubMed  Google Scholar 

  26. Chan AW, Luetjens CM, Dominko T, Ramalho-Santos J, Simerly CR, Hewitson L et al (2000) Foreign DNA transmission by ICSI: injection of spermatozoa bound with exogenous DNA results in embryonic GFP expression and live rhesus monkey births. Mol Hum Reprod 6:26–33

    Article  CAS  PubMed  Google Scholar 

  27. Ozil J-P, Banrezes B, Tóth S, Pan H, Schultz RM (2006) Ca2+ oscillatory pattern in fertilized mouse eggs affects gene expression and development to term. Dev Biol 300:534–544

    Article  CAS  PubMed  Google Scholar 

  28. Swann K, Lai FA (2013) PLCζ and the initiation of Ca(2+) oscillations in fertilizing mammalian eggs. Cell Calcium 53:55–62

    Article  CAS  PubMed  Google Scholar 

  29. Tesarik J, Sousa M (1994) Comparison of Ca2+ responses in human oocytes fertilized by subzonal insemination and by intracytoplasmic sperm injection. Fertil Steril 62:1197–1204

    CAS  PubMed  Google Scholar 

  30. Ciapa B, Arnoult C (2011) Could modifications of signalling pathways activated after ICSI induce a potential risk of epigenetic defects? Int J Dev Biol 55:143–152

    Article  CAS  PubMed  Google Scholar 

  31. Fishel S, Timson J, Lisi F, Rinaldi L (1992) Evaluation of 225 patients undergoing subzonal insemination for the procurement of fertilization in vitro. Fertil Steril 57:840–849

    CAS  PubMed  Google Scholar 

  32. Palermo G, Joris H, Derde MP, Camus M, Devroey P, Van Steirteghem A (1993) Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. Fertil Steril 59:826–835

    CAS  PubMed  Google Scholar 

  33. de Velde HV, Nagy ZP, Joris H, Vos AD, Steirteghem ACV (1997) Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Hum Reprod 12:2246–2250

    Article  PubMed  Google Scholar 

  34. Tatone C (2008) Oocyte senescence: a firm link to age-related female subfertility. Gynecol Endocrinol 24:59–63

    Article  PubMed  Google Scholar 

  35. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R et al (2008) Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 14:131–142

    Article  CAS  PubMed  Google Scholar 

  36. Carbone MC, Tatone C (2009) Alterations in the protein kinase C signaling activated by a parthenogenetic agent in oocytes from reproductively old mice. Mol Reprod Dev 76:122–131

    Article  CAS  PubMed  Google Scholar 

Download references

Declaration of Interest

The authors report no declaration of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Giovanni Artini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 International Society of Gynecological Endocrinology

About this chapter

Cite this chapter

Artini, P.G. et al. (2015). In Patients with Only One or Two Oocytes, Is IVF-ET or ICSI Better?. In: Fauser, B.C.J.M., Genazzani, A.R. (eds) Frontiers in Gynecological Endocrinology. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-09662-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09662-9_12

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09661-2

  • Online ISBN: 978-3-319-09662-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics